Up to $575,000,000 Aggregate Principal Amount of 1% Convertible Senior Notes due 2023Indenture • December 5th, 2003 • Medimmune Inc /De • Biological products, (no disgnostic substances) • New York
FIRST SUPPLEMENTAL INDENTURE, dated as of December 5, 2003 (the "First Supplemental Indenture"), between MEDIMMUNE, INC., a Delaware corporation (the "Company"), and THE BANK OF NEW YORK, a New York banking corporation, as Trustee (the "Trustee").
